Zhendong Shi

2.5k total citations
37 papers, 2.0k citations indexed

About

Zhendong Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhendong Shi has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 28 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Zhendong Shi's work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (15 papers) and RNA Interference and Gene Delivery (8 papers). Zhendong Shi is often cited by papers focused on MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (15 papers) and RNA Interference and Gene Delivery (8 papers). Zhendong Shi collaborates with scholars based in China, United States and Montenegro. Zhendong Shi's co-authors include Chunsheng Kang, Peiyu Pu, Anling Zhang, Lei Han, Luyue Chen, Yu Ren, Qian Xiao-min, Lei Han, Kailiang Zhang and Tao Jiang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Zhendong Shi

35 papers receiving 2.0k citations

Peers

Countries citing papers authored by Zhendong Shi

Since Specialization

Citations

This map shows the geographic impact of Zhendong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhendong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhendong Shi more than expected).

Fields of papers citing papers by Zhendong Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhendong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhendong Shi. The network helps show where Zhendong Shi may publish in the future.

Co-authorship network of co-authors of Zhendong Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhendong Shi. A scholar is included among the top collaborators of Zhendong Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhendong Shi. Zhendong Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nomogram for predicting axillary pathologic complete response after neoadjuvant systemic therapy in HER2 positive and triple negative breast cancer 2025 ·Journal of Cancer ·Zhendong Shi, (unknown), (unknown), Qian Xiao-min, Jie Meng, Jin Zhang	0
2	A novel Granzymes and miRNA nanocapsules co-delivery system for tumor suppression 2022 ·Biomedical Physics & Engineering Express ·Zhendong Shi, Ming Zhao, (unknown), Jiajia Chen, Qian Xiao-min	1
3	Over-Expression of Centromere Protein U Participates in the Malignant Neoplastic Progression of Breast Cancer 2021 ·Frontiers in Oncology ·Xiaomeng Hao, Yufan Qiu, Lixia Cao, Xiaonan Yang, Dongdong Zhou, Jingjing Liu, Zhendong Shi, Shaorong Zhao, (unknown)	5
4	Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer 2021 ·Frontiers in Oncology ·Lixia Cao, Shaorong Zhao, (unknown), Zhendong Shi, Jingjing Liu, Teng Pan, Dongdong Zhou, (unknown)	12
5	Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3 2020 ·Cancer Cell International ·Xuan Fang, (unknown), Chunyan Li, Jinjin Liu, Zhendong Shi, Peng Zhou	25
6	Correlation of radiotherapy with prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping 2019 ·Chinese Journal of Cancer Research ·(unknown), Xiaonan Yang, Teng Pan, Jingjing Liu, Xiaohong Chen, (unknown), Zhendong Shi, Jin Zhang	5
7	Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin–proteasomal degradation of COX-2 2019 ·Cancer Letters ·Teng Pan, Dongdong Zhou, Zhendong Shi, Yufan Qiu, (unknown), Jingjing Liu, (unknown), Lixia Cao, (unknown)	27
8	microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7 2016 ·DNA and Cell Biology ·Jingjing Liu, Yang Zhou, Zhendong Shi, Yunhui Hu, Tingting Meng, Xiaobei Zhang, Sheng Zhang, Jin Zhang	39
9	Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes 2015 ·International Journal of Oncology ·Shanshan Zhang, Lei Han, Jianwei Wei, Zhendong Shi, Peiyu Pu, Jianning Zhang, Xubo Yuan, Chunsheng Kang	30
10	BASI, A Potent Small Molecular Inhibitor, Inhibits Glioblastoma Progression by Targeting microRNA‐mediated β‐Catenin Signaling 2014 ·CNS Neuroscience & Therapeutics ·Zhendong Shi, Qian Xiao-min, Junxia Zhang, Lei Han, (unknown), (unknown), Xuan Zhou, Jianning Zhang, Chunsheng Kang	8
11	EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma 2014 ·Cancer Letters ·Junxia Zhang, Luyue Chen, Lei Han, Zhendong Shi, Jianning Zhang, Peiyu Pu, Chunsheng Kang	80
12	A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo 2014 ·Oncology Reports ·Luyue Chen, Kailiang Zhang, Zhendong Shi, Anling Zhang, Zhifan Jia, Guangxiu Wang, Peiyu Pu, Chunsheng Kang, Lei Han	66
13	ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity 2014 ·Cancer Letters ·Kailiang Zhang, (unknown), Yanwei Liu, Xiaoqun Dong, Zhendong Shi, Anling Zhang, Chaoyong Liu, Luyue Chen, Jianwei Wei, Peiyu Pu, Jianning Zhang, Tao Jiang, Lei Han, Chunsheng Kang	37
14	AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression 2013 ·Cancer Research ·Zhendong Shi, Junxia Zhang, Qian Xiao-min, Lei Han, Kailiang Zhang, Luyue Chen, Jilong Liu, Yu Ren, Ming Yang, Anling Zhang, Peiyu Pu, Chunsheng Kang	157
15	Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas 2013 ·Cancer Letters ·Kailiang Zhang, Lei Han, Luyue Chen, Zhendong Shi, Ming Yang, Yu Ren, Lingchao Chen, Junxia Zhang, Peiyu Pu, Chunsheng Kang	74
16	PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt/β-catenin pathway in a Dkk1-dependent manner during glioma growth 2013 ·Cancer Letters ·Xuan Wang, Kun Wang, Lei Han, Anling Zhang, Zhendong Shi, Kailiang Zhang, Hongwei Zhang, Shaohua Yang, Peiyu Pu, (unknown), Chunjiang Yu, Chunsheng Kang	57
17	Nuclear Translocation of β-catenin is Essential for Glioma Cell Survival 2012 ·Journal of Neuroimmune Pharmacology ·Zhendong Shi, Qian Xiao-min, (unknown), Junxia Zhang, (unknown), Jia‐Lin Zhu, Luyue Chen, Kailiang Zhang, Lei Han, Shizhu Yu, Peiyu Pu, Tao Jiang, Chunsheng Kang	52
18	VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling 2012 ·Neuro-Oncology ·Lingchao Chen, Lei Han, Kailiang Zhang, Zhendong Shi, Junxia Zhang, Anling Zhang, Yongzhi Wang, Yijun Song, Yongli Li, Tao Jiang, Peiyu Pu, Chuanlu Jiang, Chunsheng Kang	90
19	High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma 2012 ·Journal of Translational Medicine ·Chunzhi Zhang, Junxia Zhang, Jianwei Hao, Zhendong Shi, Yingyi Wang, Lei Han, Shizhu Yu, Yongping You, Tao Jiang, Jinhuan Wang, Meili Liu, Peiyu Pu, Chunsheng Kang	114
20	MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma 2010 ·Molecular Cancer ·Chunzhi Zhang, Junxia Zhang, Anling Zhang, Zhendong Shi, Lei Han, Zhifan Jia, Weidong Yang, Guangxiu Wang, Tao Jiang, Yongping You, Peiyu Pu, Cheng Jinquan, Chunsheng Kang	249

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact